The American Hospital Association on Tuesday (Sept. 18) touted a new voluntary 340B reporting program as an alternative to legislation to help achieve transparency in the 340B program, but key lawmakers and the pharmaceutical industry disagreed. House Energy & Commerce health subcommittee Chair Michael Burgess (R-TX) and Reps. Larry Bucshon (R-IN) and Buddy Carter (R-GA) told Inside Health Policy the principles are a good first step, but Bucshon and Carter said they don't remove the need for congressional action and...